GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CareMax Inc (NAS:CMAX) » Definitions » Change In Receivables

CareMax (CareMax) Change In Receivables : $40.9 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is CareMax Change In Receivables?

CareMax's change in receivables for the quarter that ended in Mar. 2024 was $7.1 Mil. It means CareMax's Accounts Receivable declined by $7.1 Mil from Dec. 2023 to Mar. 2024 .

CareMax's change in receivables for the fiscal year that ended in Dec. 2023 was $25.9 Mil. It means CareMax's Accounts Receivable declined by $25.9 Mil from Dec. 2022 to Dec. 2023 .

CareMax's Accounts Receivable for the quarter that ended in Mar. 2024 was $105.1 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. CareMax's Days Sales Outstanding for the three months ended in Mar. 2024 was 41.31.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CareMax's liquidation value for the three months ended in Mar. 2024 was $-473.5 Mil.


CareMax Change In Receivables Historical Data

The historical data trend for CareMax's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareMax Change In Receivables Chart

CareMax Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Change In Receivables
-4.21 -3.84 -66.56 25.94

CareMax Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.85 6.60 3.38 23.82 7.07

CareMax Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $40.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CareMax  (NAS:CMAX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

CareMax's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=105.148/232.246*91
=41.31

2. In Ben Graham's calculation of liquidation value, CareMax's accounts receivable are only considered to be worth 75% of book value:

CareMax's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=41.479-593.8+0.75 * 105.148+0.5 * 0
=-473.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CareMax Change In Receivables Related Terms

Thank you for viewing the detailed overview of CareMax's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


CareMax (CareMax) Business Description

Traded in Other Exchanges
N/A
Address
1000 NW 57th Court, Suite 400, Miami, FL, USA, 33126
CareMax Inc is a technology-enabled care platform providing value-based care and chronic disease management to seniors. It operates various owned medical centers that offer a comprehensive suite of healthcare and social services and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.
Executives
Bryan Cho director 30 HUDSON YARDS, 72ND FLOOR, NEW YORK NY 10001
De La Torre Ralph director, 10 percent owner 4939 BROOKVIEW DRIVE, DALLAS TX 75220
Ryan Oquinn director 1000 NW 57 COURT, SUITE 400, MIAMI FL 33126
Kevin Berg director 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Beatriz Maria Assapimonwait director 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Vincent Omachonu director 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Jose Ramon Rodriguez director PRIMORIS SERVICES CORPORATION, 2300 NORTH FIELD STREET, SUITE 1900, DALLAS TX 75201
Related Cm Advisor, Llc director 30 HUDSON YARDS, 72ND FLOOR, NEW YORK NY 10001
Imc Holdings, Lp 10 percent owner 525 OKEECHOBEE BOULEVARD, SUITE 1050, WEST PALM BEACH FL 33401
William C. Lamoreaux officer: EVP 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Kevin Wirges officer: EVP, Treasurer and CFO 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
De Solo Carlos A. director, officer: President and CEO 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Randy Simpson director C/O GLENVIEW CAPITAL MANAGEMENT, LLC, 767 FIFTH AVENUE, 44TH FLOOR, NEW YORK NY 10153
Solo Alberto De officer: EVP and COO 1000 NW 57 CT., SUITE 400, MIAMI FL 33126
Jennifer L. Carter director C/O DFP SPONSOR LLC, 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017